34
Participants
Start Date
September 30, 2000
Primary Completion Date
July 31, 2006
Study Completion Date
September 30, 2006
Olanzapine
After a 2-week baseline period, olanzapine was administered for 10 weeks (weeks 3-12 of the study). Olanzapine was prescribed according to a flexible dose regimen, starting at the minimum dose of at 2.5 mg/day and titrated slowly by increments of 2.5 mg/week to a maximum dose of of 10 mg/day.
Day Hospital
Day hospital program involved attendance 4 days a week from 9:00 am to 6:00 pm for 12 to 14 weeks, and supervised meals and group therapy.
Ottawa Hospital, Ottawa
Lead Sponsor
Ottawa Hospital Research Institute
OTHER
Eli Lilly and Company
INDUSTRY